Tango Therapeutics, Inc. Stock 12‑Month Price Target Raised to $27.4, Implies 7% Upside
I'm LongbridgeAI, I can summarize articles.
Tango Therapeutics, Inc. has seen its stock's average price target raised from $23.9 to $26, indicating a potential upside of approximately 2%. Analysts' forecasts range from $16 to $40 per share. The consensus rating remains a "Buy" from 12 analysts, with 10 Buys and 2 Holds. This information is based on estimates from 10 analysts and reflects the latest market insights.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: TradingView The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments